Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers have now uncovered the ...

A vaccine consists of immunogenic tumor-associated antigens, shaped as peptides ... a potentially important therapeutic target for immunotherapy. [42] Tumor cell vaccines expose the host immune ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...

One of the more feared complications of immunotherapy, checkpoint myocarditis is significantly ... a unique protein complex that binds and responds to foreign particles known as antigens. T-cell ...

AM003 is a first-in-class functional oligonucleotide in development for the treatment of solid tumorsFirst –in-human, monotherapy dose-escalation ...